Effects of Metreleptin in Pediatric Patients With Lipodystrophy

Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

(2016) Jean L. Chan et al.   CLINICAL ENDOCRINOLOGY

Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey

(2016) Baris Akinci et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin

(2015) Talia Diker-Cohen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy

(2015) Cristina Adelia Meehan et al.   Expert Review of Clinical Pharmacology

Bone Mineral Content in Patients With Congenital Generalized Lipodystrophy Is Unaffected by Metreleptin Replacement Therapy

(2014) John D. Christensen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Post-Liver Transplant Leptin Results in Resolution of Severe Recurrence of Lipodystrophy-Associated Nonalcoholic Steatohepatitis

(2013) S. P. Casey et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Novel Forms of Lipodystrophy: Why should we care?

(2013) K. I. Rother et al.   DIABETES CARE

Metabolic control of puberty: Roles of leptin and kisspeptins

(2013) Miguel A. Sanchez-Garrido et al.   HORMONES AND BEHAVIOR

The liver diseases of lipodystrophy: The long-term effect of leptin treatment

(2013) Elika Safar Zadeh et al.   JOURNAL OF HEPATOLOGY

Consequences of Stopping and Restarting Leptin in an Adolescent with Lipodystrophy

(2012) F. Kamran et al.   Hormone Research in Paediatrics

Lipodystrophies: Genetic and Acquired Body Fat Disorders

(2011) Abhimanyu Garg   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Rationale for Leptin-Replacement Therapy for Severe Lipodystrophy

(2010) Elif Oral et al.   Endocrine Practice

Efficacy of leptin therapy in the different forms of human lipodystrophy

(2009) A. Y. Chong et al.   DIABETOLOGIA

Type 1 Diabetes Associated with Acquired Generalized Lipodystrophy and Insulin Resistance: The Effect of Long-Term Leptin Therapy

(2007) Jean Y. Park et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM